Editors:
- Reviews major advances in molecular methods, using an evidence-based perspective
- Explores powerful tools for determining treatment decisions
- An essential resource for oncologists, dermatologists, pathologists, and melanoma researchers
- Includes supplementary material: sn.pub/extras
Part of the book series: Current Clinical Pathology (CCPATH)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (23 chapters)
-
Front Matter
About this book
This book describes both the technologies used in the discovery of melanoma biomarkers and the clinical application of these biomarkers for diagnosis and staging of disease, determination of prognosis, treatment planning, monitoring of response to therapy, identification of novel therapeutic targets and drug development. A broad range of biomarkers (DNA/chromosomal, mRNA, microRNA, mitochondrial DNA, epigenetic and protein) is outlined. As therapies for melanoma become increasingly more target specific, the identification, validation and use of biomarkers will invariably play a greater role in the management of patients with this disease. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma is an essential resource for oncologists, dermatologists, dermatopathologists, general pathologists with an interest in melanoma, and melanoma researchers.
Reviews
From the reviews:
“This is a comprehensive overview of biomarkers as they relate to pathogenesis and clinical utility in the diagnosis, staging, and treatment of melanoma. … The audience is practitioners specializing in melanoma, including dermatologists, surgeons, and oncologists, as well as researchers in the field. … book broadly explores the role of molecular diagnostic techniques and specific biomarkers which may serve to facilitate more accurate diagnoses and identify early-stage melanoma patients with high risk for metastasis. … I highly recommend this book for melanoma clinicians and researchers.” (Susan M. Swetter, Doody’s Book Reviews, July, 2012)Editors and Affiliations
-
Health Center, Department of Dermatology, University of Connecticut, Farmington, USA
Michael J. Murphy
Bibliographic Information
Book Title: Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma
Editors: Michael J. Murphy
Series Title: Current Clinical Pathology
DOI: https://doi.org/10.1007/978-1-60761-433-3
Publisher: Humana Totowa, NJ
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer Science+Business Media, LLC 2012
Hardcover ISBN: 978-1-60761-432-6Published: 01 December 2011
Softcover ISBN: 978-1-4939-6186-3Published: 23 August 2016
eBook ISBN: 978-1-60761-433-3Published: 02 December 2011
Series ISSN: 2197-781X
Series E-ISSN: 2197-7828
Edition Number: 1
Number of Pages: XIV, 322
Topics: Pathology, Oncology, Dermatology